In vitro biomarker discovery for atherosclerosis by proteomics

Molecular and Cellular Proteomics

Volumn 3, Issue 12, 2004, Pages 1200-1210

  Fach, Estelle M ^a   Garulacan, Leah Ann ^a   Gao, Ji ^a   Xiao, Qing ^a   Storm, Stephen M ^a   Dubaquie, Yves P ^a   Hefta, Stanley A ^a   Opiteck, Gregory J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN; CHITINASE; CYCLOPHILIN; FATTY ACID BINDING PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN; PROTEOME; UROKINASE RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARRIER PROTEINS; CATHEPSINS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPHILINS; CYSTEINE ENDOPEPTIDASES; DENSITOMETRY; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FOAM CELLS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; PEPTIDYLPROLYL ISOMERASE; PROTEOMICS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 12744279375     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M400160-MCP200     Document Type: Article

References (70)

1. Corti, R., and Badimon, J. (2002) Biologic aspects of vulnerable plaque. Curr. Op. Cardiol. 17, 616-625
2. Riccioni, G., De Santis, A., Cerasa, V., Menna, V., Di Ilio, C., Schiavone, C., Ballone, E., and D'Orazio, N. (2003) Atherosclerotic plaque formation and risk factors. Int. J. Immunopathol. Pharmacol. 16, 25-31
3. Vallabhajosula, S., and Fuster, V. (1997) Atherosclerosis: Imaging techniques and the evolving role of nuclear medicine. J. Nucl. Med. 38, 1788-1796
4. Raggi, P. (2001) Proceedings of the First International Meeting of the Society of Atherosclerotic Imaging, held 2-4 February 2001, in San Diego, CA. Excerpta Medica, Inc., New York, NY
5. Benzaquen, L., Yu, H., and Rifai, N. (2002) High sensitivity C-reactive protein: An emerging role in cardiovascular risk assessment. Crit. Rev. Clin. Lab. Sci. 39, 459-497
6. Libby, P., and Ridker, P. (2004) Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment. Am. J. Med. 116, (Suppl. 6A) 9S-16S.
7. Tsimikas, S., and Witztum, J. (2001) Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 103, 1930 -1932
8. Tsimikas, S., Bergmark, C., Beyer, R., Patel, R., Pattison, J., Miller, E., Juliano, J., and Witztum, J. (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J. Am. Coll. Cardiol. 41, 360-370
9. Schmitz, G., and Drobnik, W. (2003) Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy. Clin. Chem. Lab. Med. 41, 581-589
10. Hayden, J. M., Brachova, L., Higgins, K., Obermiller, L., Sevanian, A., Khandrika, S., and Reaven, P. D. (2002) Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J. Lipid Res. 43, 26-35
11. Babaei, S., Picard, P., Ravandi, A., Monge, J. C., Lee, T. C., Cernacek, P., and Stewart, D. J. (2000) Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: Role of endothelin in macrophage foam cell formation. Cardiovasc. Res. 48, 158-167
12. Zimmermann, R., Sartipy, P., Winkler, R., Zechner, R., Hurt-Camejo, E., and Kostner, G. (2000) Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins. Biochim. Biophys. Acta 1484, 316-324
13. Liao, H. S., Matsumoto, A., Itakura, H., Doi, T., Honda, M., Kodama, T., and Geng, Y. (1999) Transcriptional inhibition by interleukin-6 of the class A macrophage scavenger receptor in macrophages derived from human peripheral monocytes and the THP-1 monocytic cell line. Arterioscler. Thromb. Vasc. Biol. 19, 1872-1880
14. Rohrer, L., Freeman, M., Kodama, T., Penman, M., and Krieger, M. (1990) Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343, 570-572
15. Acton, S., Scherer, P., Lodish, H., and Krieger, M. (1994) Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269, 21003-21009
16. Ramprasad, M., Terpstra, V., Kondratenko, N., Quehenberger, O., and Steinberg, D. (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 93, 14833-14838
17. Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki, H., Murase, T., Sawamura, T., Masaki, T., Hashimoto, N., and Kita, T. (1999) Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99, 3110-3117
18. Endemann, G., Stanton, L., Madden, K., Bryant, C., White, R., and Protter, A. (1993) CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268, 11811-11816
19. Steinberg, D., Parthasarathy, S., Carew, T., Khoo, J., and Witztum, J. (1989) Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915-924
20. Brown, M., and Goldstein, J. (1983) Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223-261
21. Shiffman, D., Mikita, T., Tai, J., Wade, D., Porter, G., Seilhamer, J., Somogyi, R., Liang, S., and Lawn, R. (2000) Large scale gene expression analysis of cholesterol-loaded macrophages. J. Biol. Chem. 275, 37324-37332
22. Gygi, S. P., Rochon., Y., Franza, B. R., and Aebersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730
23. Scott, J. (2002) The pathogenesis of atherosclerosis and new opportunities for treatment and prevention. J. Neural Transm. 63, (suppl.) 1-17
24. Lopes, N., Vasudevan, S., Alvarez, R., Binkley, P., and Goldschmidt, P. (2002) Pathophysiology of plaque instability: insights at the genomic level. Prog. Cardiovasc. Dis. 44, 323-338
25. Colburn, W. A. (2003) Biomarkers in drug discovery and development: From target identification through drug marketing. J. Clin. Pharmacol. 43, 329-341
26. Colbum, W. A. (2000) Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development. J. Clin. Pharmacol. 40, 1419-1427
27. Colburn, W. A. (1997) Selecting and validating biologic markers for drug development. J. Clin. Pharmacol. 37, 355-362
28. Hammer, A., Kager, G., Dohr, G., Rab, H., Ghassempur, I., and Jurgens, G. (1995) Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified ApoB-containing serum lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15, 704-713
29. Gao, J., Garulacan, L.-A., Storm, S. M., Hefta, S. A., Opiteck, G. J., Lin, J.-H., Moulin, F., and Dambach, D. M. (2004) Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. Toxicol. In Vitro 18, 533-541
30. Opiteck, G., and Jorgenson, J. (1997) Two-dimensional SEC/RPLC coupled to mass spectrometry for the analysis of peptides. Anal. Chem. 69, 2283-2291
31. Pang, J., Ginanni, N., Dongre, A., Hefta, S., and Opitek, G. (2002) Biomarker discovery in urine by proteomics. J. Proteome Res. 1, 161-169
32. Gao, J., Opiteck, G. J., Friedrichs, M. S., Dongre, A. R., and Hefta, S. A. (2003) Changes in the protein expression of yeast as a function of carbon source. J. Proteome Res. 2, 643-649
33. Tsuchiya, S., Kobayashi, Y., Goto, Y., Okumura, H., Nakae, S., Konno, T., and Tada, K. (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42, 1530-1536
34. Lesnik, P., Dentan, C., Vonica, A., Moreau, M., and Chapman, M. (1995) Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation. Arterioscler. Thromb. Vasc. Biol. 15, 1121-1130
35. Larigauderie, G. F., Christophe, J. M., Lasselin, C., Copin, C., Fruchart, J.-C., Castro, G., and Rouis, M. (2004) Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages. Arterioscler. Thromb. Vasc. Biol. 24, 504-510
36. Yuan, X., Li, W., Brunk, U., Dalen, H., Chang, Y., and Sevanian, A. (2000) Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Rad. Biol. Med. 28, 208-218
37. Galis, Z., Sukhova, G., Lark, M., and Libby, P. (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Inv. 94, 2493-2503
38. Galis, Z., and Khatri, J. (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ. Res. 90, 251-262
39. Xu, X., Meisel, S., Ong, J., Kaul, S., Cercek, B., Rajavashisth, T., Sharifi, B., and Shah, P. (1999) Oxidized low density lipoprotein regulates matrix metalloproteinase 9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99, 993-998
40. Moreau, M., Brocheriou, I., Petit, L., Ninio, E., Chapman, J., and Rouis, M. (1999) Interleukin-8 mediates down regulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages. Circulation 99, 420-426
41. Loftus, I., Naylor, A., and Bell, P. (2001) Plasma MMP-9: A marker of carotid plaque instability. Eur. J. Vasc. Endovascul. Surg. 21, 17-21
42. Inokubo, Y., Hanada, H., Ishizaka, H., Fukushi, T., Kamada, T., and Okumura, K. (2001) Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am. Heart J. 141, 211-217
43. Blakenberg, S., Rupprecht, H., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., and Tiret, L. (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107, 1579-1585
44. Gerritsen, M. E., Soriano, R., Yang, S., Ingle, G., Zlot, C., Toy, K., Winer, J., Draksharapu, A., Peale, F., Wu, T. D., and Williams, P. M. (2002) In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. Physiol. Genomics 10, 13-20
45. Boord, J., Maeda, K., Makowski, L., Babev, V., Fazio, S., Linton, M., and Hotamisligil, G. (2002) Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 22, 1686-1691
46. Fu, Y., Luo, N., and Lopes-Virella, M. (2000) Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J. Lipid Res. 41, 2017-2023
47. Glatz, J., and Hermens, W. (2001) Fatty acid binding protein as a plasma marker for the early assessment of individuals with acute coronary syndromes. Markers Cardiol. 139-158
48. Eguchi, Y., Eguchi, N., Oda, H., Seiki, K., Kijima, Y., Matsu-ura, Y., Urade, Y., and Hayaishi, O. (1997) Expression of lipocalin-type prostaglandin D synthase (b-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc. Natl. Acad. Sci. U. S. A. 94, 14689-14694
49. Fusetti, F., von Moeller, H., Houston, D., Rozeboom, H., Dijkstra, B., Boot, R., Aerts, J., and van Aalten, D. (2002) Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins. J. Biol. Chem. 277, 25537-25544
50. Hong, B., Kwon, H., Lee, B., Kim, D., Kim, I., Kang, S.-M., Jang, Y., Cho, S., Kim, H., Jang, B., Cho, S.-Y., Kim, H.-S., Kim, M., Kwon, H., and Lee, N. (2000) Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Yonsei Med. J. 41, 82-88
51. Guo, Y., He, W., Boer, A., Wevers, R., de Bruijn, A., Groener, J., Hollak, C., and Aerts, J. (1995) Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J. Inherited Metabol. Dis. 18, 717-722
52. Boot, R., van Achterberg, T., van Aken, B., Renkema, G., Jacobs, M., Aerts, J., and De Vries, C. (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler. Thromb. Vasc. Biol. 19, 687-694
53. Artieda, M., Cenarro, A., Gañán, A., Jericó, I., Gonzalvo, C., Casado, J., Vitoria, I., Puzo, J., Pocoví, M., and Civeira, F. (2003) Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler. Thromb. Vasc. Biol. 23, 1645-1652
54. Liao, D., Jin, Z., Baas, A., Daum, G., Gygi, S., Aebersold, R., and Berk, B. (2000) Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 275, 189-196
55. Allain, F., Boutillon, C., Mariller, C., and Spik, G. (1995) Selective assay for CyPA and CyPB in human blood using highly specific anti peptide antibodies. J. Immunol. Methods. 178, 113-120
56. Li, W., Yuan, X., Olsson, A., and Brunk, U. (1998) Uptake of ox LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler. Thromb. Vasc. Biol. 18, 177-184
57. Li, W., Dalen, H., Eaton, J., and Yuan, X.-M. (2001) Apoptotic death of inflammatory cells in human atheroma. Arterioscler. Thromb. Vasc. Biol. 21, 1124-1130
58. Hakala, J. K., Oksjoki, R., Laine, P., Du, H., Grabowski, G. A., Kovanen, P. T., and Pentikainen, M. O. (2003) Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 23, 1430-1436
59. Tapper, H., and Sundler, R. (1990) Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem. J. 1990, 2
60. Chang, M., Olin, K., Tsoi, C., Wight, T., and Chait, A. (1998) Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins. J. Biol. Chem. 273, 15985-15992
61. Tao, Z., Smart, F., Figueora, J., Glancy, D., and Vijayagopal, P. (1997) Elevated expression of proteoglycans in proliferating vascular smooth muscle cells. Atherosclerosis. 135, 171-179
62. Vijayagopal, P., and Glancy, D. (1996) Macrophages stimulate cholesteryl ester accumulation in cocultured smooth muscle cells incubated with lipoprotein-proteoglycan complex. Arterioscler. Thromb. Vasc. Biol. 16, 1112-1121
63. Keidar, S., and Attias, J. (1997) Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a protetoglycan-mediated pathway. Biochem. Biophys. Res. Commun. 239, 63-67
64. Mas-Oliva, J., Arnold, K., Wagner, W., William, D., Phillips, D., and Pitas, R. (1994) Isolation and characterization of a platelet-derived macrophage-binding proteoglycan. J. Biol. Chem. 269, 10177-10183
65. Volker, W., Schmidt, A., Oortmann, W., Broszey, T., Faber, V., and Buddecke, E. (1990) Mapping of proteoglycans in atherosclerotic lesions. Eur. Heart J. 11, 29-40
66. Hsu, H.-Y., Hajjar, D., Khan, K., and Falcone, D. (1998) Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J. Biol. Chem. 273, 1240-1246
67. Ganne, F., Vasse, M., Beaudeux, J.-L., Peynet, J., Francois, A., Paysant, J., Lenormand, B., Collet, J.-P., Vannier, J.-P., Soria, J., Soria, C. (1999) Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins. Thromb. Haemost. 81, 594-600
68. Takahashi, K., Takeya, M., and Sakashita, N. (2002) Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med. Electron Microsc. 35, 179-203
69. Podrez, E., Hoppe, G., O'Neil, J., Hoff, H. (2003) Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor. Free Rad. Biol. Med. 34, 356-364
70. Han, J., and Nicholson, A. (1998) Lipoproteins modulate expression of the macrophage scavenger receptor. J. Pathol. 152, 1647-1654